Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
New combo therapy aims to keep aggressive lung cancer at bay
Disease control Not yet recruitingThis study is testing whether a combination of two drugs, lurbinectedin and durvalumab, can help control extensive-stage small cell lung cancer after initial chemotherapy. It is for patients whose cancer has not gotten worse after their first round of treatment. The main goal is …
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
First human tests begin for new drug JZP047
Knowledge-focused Not yet recruitingThis is a very early study to check the safety of a new drug called JZP047 and see how the body processes it. It will involve about 86 healthy adults. Researchers will give different single doses to see what happens and will also test if taking the drug with food makes a differen…
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:06 UTC